Immuneering (IMRX) Change in Accured Expenses (2020 - 2026)

Immuneering's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$247323.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 84.63% year-over-year to -$247323.0; the TTM figure through Mar 2026 stood at $1.4 million (up 190.2% YoY), while the FY2025 annual figure was $57848.0, up 128.8% from the prior year.
• Change in Accured Expenses was -$247323.0 for Q1 2026 at Immuneering, down from $211424.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q3 2022 to a low of -$1.8 million in Q2 2022.
• Historically, Change in Accured Expenses has averaged $21967.4 across 5 years, with a median of $30350.5 in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 3712.3% in 2024, then jumped 29546.24% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$24766.0 in 2022, then surged by 2770.14% to $661288.0 in 2023, then sank by 100.11% to -$718.0 in 2024, then surged by 29546.24% to $211424.0 in 2025, then slumped by 216.98% to -$247323.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$247323.0 (Q1 2026), $211424.0 (Q4 2025), and $304594.0 (Q3 2025), per Business Quant data.